Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
July 1, 1976
Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA
D H Kern, D Fritze, C R Drogemuller, et al.
Cancer Research
|
February 1, 1976
Production of antisera with specificity for malignant melanoma and human fetal skin
D Fritze, D H Kern, C R Drogemuller, et al.
Transplantation
|
September 1, 1975
A new micromethod for the detection of HL-A antigens on cultured human tumor cells
D Fritze, D H Kern, C R Drogemuller, et al.
International Journal of Cancer
|
January 15, 1975
Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas
D Fritze, D H Kern, S R Waldman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2001
Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts
H Pilch, K Schlenger, E Steiner, et al.
The Journal of Laboratory and Clinical Medicine
|
December 1, 1975
Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro
S R Waldman, J A Roth, D H Kern, et al.
Zentralblatt Fur Gynakologie
|
September 27, 2006
Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions
I Zehbe, M Schmidt, M Maeurer, et al.
Journal of Surgical Oncology
|
May 1, 1986
Needle biopsies in breast cancer diagnosis: techniques in search of an audience
H J Smeets, S L Saltzstein, W T Meurer, et al.
Annals of Surgery
|
August 1, 1982
Aspiration cytology is superior to Tru-Cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses
M M Shabot, I M Goldberg, P Schick, et al.
Zentralblatt Fur Gynakologie
|
June 19, 2002
[Expression of c-erbB-2 and topoisomerase II alpha in relation to chemoresistance in ovarian cancer]
B Tanner, H Pilch, U Schäffer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
July 1, 1976
Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA
D H Kern, D Fritze, C R Drogemuller, et al.
Cancer Research
|
February 1, 1976
Production of antisera with specificity for malignant melanoma and human fetal skin
D Fritze, D H Kern, C R Drogemuller, et al.
Transplantation
|
September 1, 1975
A new micromethod for the detection of HL-A antigens on cultured human tumor cells
D Fritze, D H Kern, C R Drogemuller, et al.
International Journal of Cancer
|
January 15, 1975
Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas
D Fritze, D H Kern, S R Waldman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2001
Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts
H Pilch, K Schlenger, E Steiner, et al.
The Journal of Laboratory and Clinical Medicine
|
December 1, 1975
Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro
S R Waldman, J A Roth, D H Kern, et al.
Zentralblatt Fur Gynakologie
|
September 27, 2006
Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions
I Zehbe, M Schmidt, M Maeurer, et al.
Journal of Surgical Oncology
|
May 1, 1986
Needle biopsies in breast cancer diagnosis: techniques in search of an audience
H J Smeets, S L Saltzstein, W T Meurer, et al.
Annals of Surgery
|
August 1, 1982
Aspiration cytology is superior to Tru-Cut needle biopsy in establishing the diagnosis of clinically suspicious breast masses
M M Shabot, I M Goldberg, P Schick, et al.
Zentralblatt Fur Gynakologie
|
June 19, 2002
[Expression of c-erbB-2 and topoisomerase II alpha in relation to chemoresistance in ovarian cancer]
B Tanner, H Pilch, U Schäffer, et al.
Page
of 7